Cytokine networks in glioma

Kenichiro Iwami1, Atsushi Natsume, Toshihiko Wakabayashi

  • 1Department of Neurosurgery, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Japan.

Neurosurgical Review
|June 10, 2011
PubMed

Insights

This review explores cytokine communication within the brain tumor microenvironment. It examines how these signaling molecules influence glioma growth and discusses current cytokine-based therapies for brain tumors.

Area of Science:

  • Oncology
  • Immunology
  • Neuroscience

Background:

  • Glioma, the most common brain tumor, has a poor patient prognosis despite current treatments.
  • Cytokines are crucial signaling molecules in the tumor microenvironment, influencing cell behavior.
  • Tumor microenvironments comprise heterogeneous cells and extracellular matrix, essential for tumor growth and progression.

Purpose of the Study:

  • To review the communication pathways involving cytokines within the glioma microenvironment.
  • To summarize existing cytokine therapies for treating gliomas.

Main Methods:

  • Literature review of studies on glioma, tumor microenvironment, and cytokines.
  • Analysis of cytokine roles in glioma pathogenesis and progression.
  • Evaluation of current and emerging cytokine-based therapeutic strategies.

Main Results:

  • Cytokines play a dual role (pro- or anti-inflammatory, immunosuppressive) within the tumor microenvironment.
  • Tumor cells actively modulate the microenvironment through cytokine production for growth and survival.
  • Cytokine cross-talk is a key mechanism in glioma development and progression.

Conclusions:

  • Understanding cytokine networks in the glioma microenvironment is vital for developing effective treatments.
  • Targeting cytokine signaling presents a promising avenue for novel glioma therapeutic strategies.
  • Further research into cytokine-based therapies could improve outcomes for glioma patients.